Survival benefit of extended D2 lymphadenectomy in gastric cancer with involvement of second level lymph nodes: A longitudinal multicenter study

Annals of Surgical Oncology

Volumn 9, Issue 9, 2002, Pages 894-900

  Roviello, Franco ^a   Marrelli, Daniele ^a   Morgagni, Paolo ^b   De Manzoni, Giovanni ^c   Di Leo, Alberto ^c   Vindigni, Carla ^a   Saragoni, Luca ^d   Tomezzoli, Anna ^a   Kurihara, Hayato ^e  

^a UNIVERSITY OF SIENA   (Italy)

^b MORGAGNI PIERANTONI HOSPITAL   (Italy)

^c UNIVERSITY OF VERONA   (Italy)

^d Pierantoni Hospital of Forli   (Italy)

^e UNIVERSITY OF MILAN   (Italy)

Author keywords

Follow up; Gastric cancer; Lymph node metastasis; Lymphadenectomy; Prognostic factors; Surgery

Indexed keywords

ADULT; AGED; ARTICLE; BILE DUCT INJURY; CANCER INVASION; CANCER MORTALITY; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; INTESTINE OBSTRUCTION; INTESTINE PERFORATION; LONGITUDINAL STUDY; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTICENTER STUDY; PANCREATITIS; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE INFECTION; PROGNOSIS; STENOSIS; STOMACH CANCER; SURGICAL TECHNIQUE; SURVIVAL TIME; TREATMENT OUTCOME;

EID: 0036840856     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02557527     Document Type: Article

References (25)

1. Wanebo HJ, Kennedy BJ, Chmiel J. Cancer of the stomach: A patient care study by the American College of Surgeons. Ann Surg 1993;218:583-92.
2. Roder JD, Bottcher K, Siewert JR, Busch R, Hermanek P, Meyer HJ. Prognostic factors in gastric carcinoma. Results of the German Gastric Carcinoma Study 1992. Cancer 1993;72:2089-97.
3. Maruyama K, Sasako M, Kinoshita T, et al. Should systematic lymph node dissection be recommended for gastric cancer? Eur J Cancer 1998;34:1480-9.
4. Maruyama K, Okabayashi K, Kinoshita T. Progress in gastric cancer surgery in Japan and its limits of radicality. World J Surg 1987;11:418-25.
5. Roukos DH, Lorenz M, Encke A. Evidence of survival benefit of extended (D2) lymphadenectomy in western patients with gastric cancer based on a new concept: A prospective long-term follow-up study. Surgery 1998;123:573-8.
6. Siewert JR, Bottcher K, Stein HJ, Roder JD. Relevant prognostic factors in gastric cancer: Ten-year results of the German Gastric Cancer Study. Ann Surg 1998;228:449-61.
7. Pacelli F, Doglietto GB, Bellantone R, Alfieri S, Sgadari A, Crucitti F. Extensive versus limited lymph node dissection for gastric cancer: A comparative study of 320 patients. Br J Surg 1993;80:1153-6.
8. Bonenkamp JJ, Hermans J, Sasako M, van de Velde CJ. Extended lymph-node dissection for gastric cancer. Dutch Gastric Cancer Group. N Engl J Med 1999;340:908-14.
9. Cuschieri A, Weeden S, Fielding J, et al. Patient survival after D1 and D2 resections for gastric cancer: Long-term results of the MRC randomized surgical trial. Surgical Co-operative Group. Br J Cancer 1999;79:1522-30.
10. Japanese Research Society for Gastric Cancer. Japanese Classification of Gastric Carcinoma. Tokyo: Kaneara & Co., Ltd., 1995.
11. Lauren P. The two histological main types of gastric carcinoma: Diffuse and so-called intestinal-type carcinoma. Acta Pathol Microbiol Scand 1965;64:31-49.
12. Sobin LH, Wittekind C. TNM Classification of Malignant Tumors. 5th Ed. New York: John Wiley, 1997:59-62.
13. Jatzko GR, Lisborg PH, Denk H, Klimpfinger M, Stettner HM. A 10-year experience with Japanese-type radical lymph node dissection for gastric cancer outside of Japan. Cancer 1995;76:1302-12.
14. de Manzoni G, Verlato G, Guglielmi A, Laterza E, Genna M, Cordiano C. Prognostic significance of lymph node dissection in gastric cancer. Br J Surg 1996;83:1604-7.
15. Kasakura Y, Fujii M, Mochizuki F, Kochi M, Kaiga T. Is there a benefit of pancreaticosplenectomy with gastrectomy for advanced gastric cancer? Am J Surg 2000;179:237-42.
16. Schmid A, Thybusch A, Kremer B, Henne-Bruns D. Differential effects of radical D2-lymphadenectomy and splenectomy in surgically treated gastric cancer patients. Hepatogastroenterology 2000; 47:579-85.
17. Maruyama K, Gunven P, Okabayashi K, Sasako M, Kinoshita T. Lymph node metastases of gastric cancer. General pattern in 1931 patients. Ann Surg 1989;210:596-602.
18. Sasako M, McCulloch P, Kinoshita T, Maruyama K. New method to evaluate the therapeutic value of lymph node dissection for gastric cancer. Br J Surg 1995;82:346-51.
19. Hermanek P. PTNM and residual tumor classifications: Problems of assessment and prognostic significance. World J Surg 1995;19: 184-90.
20. Siewert JR, Kestlmeier R, Busch R, et al. Benefits of D2 lymph node dissection for patients with gastric cancer and pN0 and pN1 lymph node metastases. Br J Surg 1996;83:1144-7.
21. De Manzoni G, Verlato G, Guglielmi A, et al. Classification of lymph node metastases from carcinoma of the stomach: Comparison of the old (1987) and new (1997) TNM systems. World J Surg 1999;23:664-9.
22. Hayashi H, Ochiai T, Suzuki T, Shimada H, Hori S, Takeda A, Miyazawa Y. Superiority of a new UICC-TNM staging system for gastric carcinoma. Surgery 2000;127:129-35.
23. Yu W, Whang I, Suh I, Averbach A, Chang D, Sugarbaker PH. Prospective randomized trial of early postoperative intraperitoneal chemotherapy as an adjuvant to resectable gastric cancer. Ann Surg 1998;228:347-54.
24. Fujimura T, Yonemura Y, Muraoka K, et al. Continuous hyperthermic peritoneal perfusion for the prevention of peritoneal recurrence of gastric cancer: Randomized controlled study. World J Surg 1994;18:150-5.
25. Fujimoto S, Takahashi M, Mutou T, Kobayashi K, Toyosawa T. Successful intraperitoneal hyperthermic chemoperfusion for the prevention of postoperative peritoneal recurrence in patients with advanced gastric carcinoma. Cancer 1999;85:529-34.